SAN FRANCISCO — In this Healio Video Perspective from Eyecelerator@AAO, Nick Ruth, MBA, of Sydnexis previews upcoming data for a progressive myopia treatment for pediatric patients.
The treatment “is at the tail end of its phase 3 clinical trials,” and the company anticipates unmasking the data in the second quarter of 2024, he said.